​How Owens & Minor Builds Medical Gains in Logistics

MoneyShow  |

Owens & Minor (OMI) is a healthcare logistics company specializing in contracting packages of healthcare products for hospitals, notes dividend reinvestment expert Vita Nelson, editor of DirectInvesting.

The company provides supply chain services to healthcare providers and manufacturers of healthcare products, including disposable medical supplies as well as devices and implants.

It is considered a diversified business with competitive advantage over its rivals and the company enjoys a solid management and excellent corporate culture.

It has paid dividends to investors since 1926 and has increased its payments for 19 consecutive years. During the past five years, it has increased dividends at an average rate of 3.7%, with its quarterly payment of $0.26 currently providing a yield of 4.20%.

Its price to earnings ratio of 15.6 is 39.3% below the S&P 500 Index’s current P/E, and according to Morningstar, the stock is trading 33.6% below its Fair Value Estimate, making it attractive for investors with a long-term investment horizon. Technically, the stock is trading 40.9% below its all-time high and 33.6% below its 52-week high.

OMI’s dividend reinvestment plan charges no fees for cash investing, dividend reinvestment, automatic investment or termination of the plan. With the stock being fundamental and technically attractive, this may be an excellent entry point for investors with a longer-term investment horizon.

Vita Nelson is editor of DirectInvesting.

Subscribe to Vita Nelson's DirectInvesting here…

About MoneyShow.com: Founded in 1981, MoneyShow is a privately held financial media company headquartered in Sarasota, Florida. As a global network of investing and trading education, MoneyShow presents an extensive agenda of live and online events that attract over 75,000 investors, traders and financial advisors around the world.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not necessarily represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer.

Market Movers

Sponsored Financial Content